2018 Stanford Drug Discovery Conference
April 23-24, 2018
Li Ka Shing Conference Center
| Register Here |
| Shark Tank Application |
Now accepting applications for translational stage projects to be presented to a panel of leading scientists, CEOs, and entrepreneurs.
This is a great way to showcase your company, receive informal feedback from industry experts, and network with industry/academia/VC leaders. There is no financial obligation or guarantee of investment. There will be a non-monetary prize for best product/business plan.
The Shark Tank panel includes Roy Vagelos, MD; George Scangos, PhD; Ram Shriram; Robert Robbins, MD; and Amy Chang
Agenda
Day 1 | April 23, 2018
Welcoming Remarks and Introduction
Joseph Wu, MD, PhD | Director, Stanford Cardiovascular Institute
Lloyd Minor, MD | Dean, Stanford School of Medicine
David Entwistle | CEO, Stanford Health Care
Dennis Lund, MD | Chief Medical Officer, Lucille Packard Children’s Hospital Stanford
Opening Keynote
Brian Kobilka, MD | "Structure-based Approaches for G Protein Coupled Receptor Drug Discovery"
Q & A Session
Academic Drug Discovery Process
Session Chairs and Moderators: Janet Woodcock, MD, and Joseph Wu, MD, PhD
Kathleen Giacomini, PhD
Kevan Shokat, PhD | "Chemical Tricks for Drugging the Undruggable"
Hugh Rosen, MD, PhD | "Intelligent Intervention: Ozanimod from Hit to NCE at Scripps"
Edgar Engleman, MD | "Treating Disease by Manipulating the Immune System"
Panel Discussion
View From the Top
Ken Frazier | "Inventing for Life: the CEO Perspective"
Joe Jimenez | "Outcomes Based Pricing"
Patrick Soon-Shiong, MD | "Patient as the Biological Factory of the Future"
Bob Bradway | "Moving from 'Break/Fix' to 'Predict/Prevent'"
Brent Saunders | "Using the Innovation Ecosystem to Build a Robust Pipeline"
Sanford Weill | "Philanthropy's Vital Role in Partnering with Healthcare"
Panel Discussion
Fireside Chat
Marc Tessier-Lavigne, FRS, FRSC, FMedSci
Lloyd Minor, MD
Q & A Session
Presentation of Lifetime Achievement Award to Roy Vagelos, MD
Introduction: Paul Berg, PhD, and Ken Frazier
Awardee Lecture: Roy Vagelos, MD | "A Career in Drug Discovery"
Day 2 | April 24, 2018
Keynote Address
Kuldev Singh, MD | Introduction
Janet Woodcock, MD | "Changes on the Horizon for the New Drug Regulatory Program"
Q & A Session
Publishing Drug Discovery
Session Chair and Moderator: Sanjay Malhotra, PhD
Howard Bauchner, MD | "Evolving Issues in Medical Journalism"
John Keaney, MD | "Editorial Considerations in the Evaluation of New Therapies"
Paula Kiberstis, PhD | "Drug Discovery and Science: What's behind the Curtain?"
Joao Monteiro, MD, PhD | "Transparency and Reproducibility in Science: How Journals Can Help"
Round Table Discussion
Funding Agency Perspectives
Session Chair and Moderator: Joseph Wu, MD, PhD
Gary Gibbons, MD | "Charting Our Future Together: Advancing Discovery Science for Public Health Impact"
Maria Millan, MD
Q & A Session
Starting Up
George Scangos, PhD | "Transitioning from Big Pharma to Startup"
Shark Tank-style Panel featuring:
Roy Vagelos, MD
George Scangos, PhD
Ram Shriram
Robert Robbins, MD
Amy Chang
Wende Hutton
Closing Remarks / Poster Prize Award Announcement